iCo Therapeutics Inc (CVE:ICO) shares shot up 20% on Monday . The stock traded as high as C$0.06 and last traded at C$0.06. 497,300 shares traded hands during mid-day trading, an increase of 121% from the average session volume of 225,309 shares. The stock had previously closed at C$0.05.
The company has a market cap of $4.37 million and a P/E ratio of -2.50.
iCo Therapeutics Company Profile (CVE:ICO)
iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.
Featured Story: Why is cost of goods sold important?